top of page

For Patients
For Healthcare Professionals
- Treating Stage 4 ROS1 (for HCPs)
- ROS1 Clinical Trials
Our Research
Blog
About Us
More

Use tab to navigate through the menu items.

ROS1ders Blog

Articles and Resources for ROS1+ Patients, Families, and Health Professionals.

All Posts
Advocacy
Biomarker Testing
Events
Patient-Driven Research
Cancer Progression
Research
Resources
Survivorship
Treatments and Trials
Fundraising
ROS1ders Stories

Search

FDA Accepts New Drug Application for Zidesamtinib—A Potential New Option for ROS1-Positive NSCLC Patients

FDA Accepts New Drug Application for Zidesamtinib—A Potential New Option for ROS1-Positive NSCLC Patients

FDA Accepts New Drug Application for Zidesamtinib—A Potential New Option for ROS1-Positive NSCLC Patients

Dec 19, 20251 min read

Virtual Webinar: Living with ROS1+ Lung Cancer

Virtual Webinar: Living with ROS1+ Lung Cancer

Virtual Webinar: Living with ROS1+ Lung Cancer

Nov 12, 20251 min read

Living with ROS1+ Cancer: Strategies for Emotional Well-Being and Mental Health

Living with ROS1+ Cancer: Strategies for Emotional Well-Being and Mental Health

Living with ROS1+ Cancer: Strategies for Emotional Well-Being and Mental Health

Oct 15, 20253 min read

Coping with Digestive Side Effects from ROS1+ Targeted Therapy

Coping with Digestive Side Effects from ROS1+ Targeted Therapy

Coping with Digestive Side Effects from ROS1+ Targeted Therapy

Sep 17, 20252 min read

Thanks Bonnie Addario for believing in The ROS1ders

Thanks Bonnie Addario for believing in The ROS1ders

Thanks Bonnie Addario for believing in The ROS1ders

Janet Freeman-Daily

Aug 29, 20251 min read

Jing Liu: She's a 1der

Jing Liu: She's a 1der

Jing Liu: She's a 1der

Aug 22, 20255 min read

Promising Data for a New ROS1+ cancer treatment

Promising Data for a New ROS1+ cancer treatment

Promising Data for a New ROS1+ cancer treatment

Jul 2, 20252 min read

The Role of Biomarkers in ROS1+ Cancer Treatment

The Role of Biomarkers in ROS1+ Cancer Treatment

The Role of Biomarkers in ROS1+ Cancer Treatment

May 7, 20252 min read

Global perspectives

Global perspectives

Global Perspectives on ROS1+ Cancer

Mar 27, 20253 min read

Managing Weight Gain: A Common Side Effect of ROS1 Targeted Therapy

Managing Weight Gain: A Common Side Effect of ROS1 Targeted Therapy

Managing Weight Gain: A Common Side Effect of ROS1 Targeted Therapy

Feb 5, 20254 min read

Understanding and Managing Brain Fog as a Side Effect of ROS1 Targeted Therapy

Understanding and Managing Brain Fog as a Side Effect of ROS1 Targeted Therapy

Understanding and Managing Brain Fog as a Side Effect of ROS1 Targeted Therapy

Jan 8, 20253 min read

For every $1 you donate today, we will get $2!

For every $1 you donate today, we will get $2!

For every $1 you donate today, we will get $2!

Nov 4, 20241 min read

A Legacy of Hope: Eunice Ring Fights ROS1+ Cancer Through Research and Community

A Legacy of Hope: Eunice Ring Fights ROS1+ Cancer Through Research and Community

A Legacy of Hope: Eunice Ring Fights ROS1+ Cancer Through Research and Community

Oct 30, 20243 min read

Understanding Visual Disturbances: Side Effects of Targeted Therapy Drugs in ROS1+ Cancer Treatment

Understanding Visual Disturbances: Side Effects of Targeted Therapy Drugs in ROS1+ Cancer Treatment

Understanding Visual Disturbances: Side Effects of Targeted Therapy Drugs in ROS1+ Cancer Treatment

Oct 15, 20242 min read

Understanding Edema: Side Effects of Targeted Therapy Drugs in ROS1+ Cancer Treatment

Understanding Edema: Side Effects of Targeted Therapy Drugs in ROS1+ Cancer Treatment

Understanding Edema: Side Effects of Targeted Therapy Drugs in ROS1+ Cancer Treatment

Jul 18, 20243 min read

Diana Casas: She's a 1der

Diana Casas: She's a 1der

Diana Casas: She's a 1der

May 29, 20242 min read

The ROS1ders Announce Recipient of Eunice and Milton Ring Grant for ROS1 Cancer Research

The ROS1ders Announce Recipient of Eunice and Milton Ring Grant for ROS1 Cancer Research

The ROS1ders Announce Recipient of Eunice and Milton Ring Grant for ROS1 Cancer Research

Janet Freeman-Daily

May 28, 20241 min read

Immunotherapy & ROS1+ Cancer

Immunotherapy & ROS1+ Cancer

Immunotherapy & ROS1+ Cancer

Apr 25, 20242 min read

2024 ROS1+ Cancer Innovation Award is open for submissions

2024 ROS1+ Cancer Innovation Award is open for submissions

2024 ROS1+ Cancer Innovation Award is open for submissions

Janet Freeman-Daily

Apr 1, 20241 min read

Navigating the Unknown: Common Fears about Clinical Trials for ROS1 Cancer Targeted Therapy

Navigating the Unknown: Common Fears about Clinical Trials for ROS1 Cancer Targeted Therapy

Navigating the Unknown: Common Fears about Clinical Trials for ROS1 Cancer Targeted Therapy

Mar 13, 20243 min read

ROS1+ Cancer Treatment other than Targeted Therapies

ROS1+ Cancer Treatment other than Targeted Therapies

ROS1+ Cancer Treatment other than Targeted Therapies

Feb 7, 20243 min read

Lung Cancer Considered Podcast: FDA approval of repotrectinib

Lung Cancer Considered Podcast: FDA approval of repotrectinib

Lung Cancer Considered Podcast: FDA approval of repotrectinib

Dec 6, 20231 min read

Patrick Bainée : He's a 1der

Patrick Bainée : He's a 1der

Patrick Bainée : He's a 1der

Nov 24, 20232 min read

Lenny Bvh : She's a 1der

Lenny Bvh : She's a 1der

Lenny Bvh : She's a 1der

Nov 17, 20231 min read

The ROS1ders, Inc.
1721 Eastern Avenue, Suite 19
Sacramento, CA 95864
+1 (916) 382-8544
info@theros1ders.org

A 501(c)(3) nonprofit corporation
EIN 83-4490547

Disclosures

This website is not intended to, and does not provide, medical advice, professional diagnosis, opinion, treatment, or services. Medical information provided on this site is for informational and educational purposes only. After reading content from this website, you are encouraged to review the information carefully with your physician.

Connect with Our Community

Join Private Facebook Group

Email Webmaster

bottom of page